Point Field Partners

Family office · Baltimore, Maryland

Point Field Partners is a Single Family Office based in Baltimore, Maryland. 6 portfolio companies are on record.

AUM
—
Portfolio companies
6
Recorded deals
1
Last investment
—

Point Field Partners key facts

  • Point Field Partners is a family office based in Baltimore, Maryland with 6 tracked portfolio companies.
  • Notable positions include Delfi Diagnostics, Clear Skye, Veralox Therapeutics.
  • The team roster lists 1 person.

About Point Field Partners

Point Field Partners is a Single Family Office based in Baltimore, Maryland. The assets of the firm are managed by the executive team.

Point Field Partners portfolio at a glance

6 portfolio companies are on record for Point Field Partners, including Delfi Diagnostics, Clear Skye and Veralox Therapeutics.

5 of the 6 carry a recorded valuation.

Point Field Partners team

1 person is on record at Point Field Partners. Senior names include Ju Kim (Investment Professional). 1 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 6 recorded positions
  • ·Watchlist + alerts for Point Field Partners's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

6 companies · priced for members
CompanyValuationRole
Delfi Diagnostics▮▮
Clear Skye▮▮
Veralox Therapeutics▮▮
+ 3 more companies · all 6, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Team
1 people on record — 1 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Point Field Partners

What companies does Point Field Partners invest in?
Point Field Partners has 6 recorded portfolio companies, including Delfi Diagnostics, Clear Skye, Veralox Therapeutics.